Chiara Ghetti1, Laura C Skoczylas, Sallie S Oliphant, Cara Nikolajski, Jerry L Lowder. 1. From the *Division of Urogynecology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA; †Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Washington University, St Louis, MO; ‡Department of Obstetrics and Gynecology, Kaiser Permanente West Los Angeles, Los Angeles, CA; §Division of Urogynecology, Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR; and ∥UPMC Center for High-Value Health Care, Pittsburgh, PA.
Abstract
OBJECTIVE: We aimed to qualitatively describe the emotional burden experienced by women seeking treatment for prolapse. We hypothesized that the condition of prolapse would have an impact on women's emotional well-being. METHODS: Women with stage II or greater symptomatic prolapse participated in focus groups or individual phone interviews. A trained facilitator conducted semi-structured focus groups and interviews. These were audio-taped and transcribed. Two authors coded transcripts and identified themes using an "editing" approach. The codebook was amended until no new major themes emerged from the data. RESULTS: Forty-four women participated (25 in focus groups and 19 in phone interviews). Mean (SD) age of women was 60 (10) years and mean (SD) prolapse leading edge was 3 (2) cm. Analysis revealed the following 3 main themes: (1) emotions associated with the condition of prolapse (minimal emotions, annoyance, irritation, frustration, anger, sadness, anxiety, depression), (2) communicating emotions related to prolapse (to friends, family, healthcare providers), and (3) emotions relating to treatment (both positive and negative effects). CONCLUSIONS: Prolapse significantly impacts women's emotional health and subjective well-being. An improved understanding of women's emotional experiences of prolapse may help providers better meet patients' needs.
OBJECTIVE: We aimed to qualitatively describe the emotional burden experienced by women seeking treatment for prolapse. We hypothesized that the condition of prolapse would have an impact on women's emotional well-being. METHODS:Women with stage II or greater symptomatic prolapse participated in focus groups or individual phone interviews. A trained facilitator conducted semi-structured focus groups and interviews. These were audio-taped and transcribed. Two authors coded transcripts and identified themes using an "editing" approach. The codebook was amended until no new major themes emerged from the data. RESULTS: Forty-four women participated (25 in focus groups and 19 in phone interviews). Mean (SD) age of women was 60 (10) years and mean (SD) prolapse leading edge was 3 (2) cm. Analysis revealed the following 3 main themes: (1) emotions associated with the condition of prolapse (minimal emotions, annoyance, irritation, frustration, anger, sadness, anxiety, depression), (2) communicating emotions related to prolapse (to friends, family, healthcare providers), and (3) emotions relating to treatment (both positive and negative effects). CONCLUSIONS: Prolapse significantly impacts women's emotional health and subjective well-being. An improved understanding of women's emotional experiences of prolapse may help providers better meet patients' needs.
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Jerry L Lowder; Chiara Ghetti; Cara Nikolajski; Sallie S Oliphant; Halina M Zyczynski Journal: Am J Obstet Gynecol Date: 2011-02-02 Impact factor: 8.661
Authors: Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody Journal: JAMA Date: 2008-09-17 Impact factor: 56.272
Authors: Hannah G Krause; Barbara A Hall; Shu-Kay Ng; Harriet Natukunda; Isaac Singasi; Judith T W Goh Journal: Int Urogynecol J Date: 2016-11-07 Impact factor: 2.894
Authors: Sarah A Collins; Michele O'Shea; Nicola Dykes; Olga Ramm; Autumn Edenfield; Ka Lai Shek; Kim van Delft; Molly Beestrum; Kimberly Kenton Journal: Int Urogynecol J Date: 2021-06-30 Impact factor: 2.894
Authors: Casey L Kinman; Courtney A Lemieux; Anubhav Agrawal; Jeremy T Gaskins; Kate V Meriwether; Sean L Francis Journal: Int Urogynecol J Date: 2016-10-20 Impact factor: 2.894
Authors: Rahel Nardos; Fekade Ayenachew; Renate Roentgen; Melaku Abreha; Laura Jacobson; Amanuel Haile; Yibrah Berhe; Karen Gold; W Thomas Gregory; Theresa Spitznagle; Christopher K Payne; L Lewis Wall Journal: Int Urogynecol J Date: 2020-01-03 Impact factor: 2.894
Authors: Musa Kayondo; Dan Kabonge Kaye; Richard Migisha; Rodgers Tugume; Paul Kalyebara Kato; Henry Mark Lugobe; Verena Geissbüehler Journal: BMC Womens Health Date: 2021-06-25 Impact factor: 2.809
Authors: Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey Arnold; Christopher V Almario; Brennan M R Spiegel; Jennifer T Anger Journal: Female Pelvic Med Reconstr Surg Date: 2021-02-01 Impact factor: 1.913